Thomas Ciaran Loughman

Title: Innovations of Thomas Ciaran Loughman

Introduction

Thomas Ciaran Loughman is an accomplished inventor based in Killester, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations for somatostatin analogs. With a total of two patents to his name, Loughman's work is recognized for its innovative approach to drug delivery systems.

Latest Patents

Loughman's latest patents focus on processes for the preparation of pharmaceutical compositions that ensure the sustained release of somatostatin analogs. One of his notable inventions involves a method for preparing injectable pharmaceutical compositions by lyophilizing a mixture of lanreotide acetate and acetic acid. This process is designed to create a lyophilizate that can be hydrated for effective drug delivery. Another patent outlines a similar process, emphasizing the importance of combining lanreotide acetate and acetic acid, lyophilizing the mixture only once, and hydrating the resulting lyophilizate. The addition of acetic acid to achieve a desired pH during the final step is also highlighted in his work.

Career Highlights

Loughman is currently associated with Ipsen Pharma S.a.s., where he continues to innovate in the pharmaceutical sector. His expertise in drug formulation and delivery systems has positioned him as a valuable asset in his field.

Collaborations

Some of Loughman's notable coworkers include Martin Montes and Chantal Roume, who contribute to the collaborative environment at Ipsen Pharma S.a.s.

Conclusion

Thomas Ciaran Loughman's contributions to pharmaceutical innovations, particularly in the area of sustained release formulations, demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of drug delivery mechanisms, which can significantly impact patient care.